Ibrutinib Cipla contains Ibrutinib, 140mg capsules, supplied as oral. Manufacturer: Cipla. Therapeutic class: BTK Inhibitor.
Prescription-only medicine. Supplied against a named-patient prescription, or to holders of a valid drug import or wholesale licence in the destination country.
For indications, dosing and safety information, refer to the approved product label in the prescriber’s country.